Severe Candida infections in critically ill patients with COVID-19
Despoina Koulenti(The University of Queensland), Stijn Blot(The University of Queensland), Marios Karvouniaris(AHEPA University Hospital), Paschalis Paranos(National and Kapodistrian University of Athens), Joseph Meletiadis(National and Kapodistrian University of Athens), Νικόλαος Μάρκου(Thriasio General Hospital of Elefsina), Elisabeth Paramythiotou(Laiko General Hospital of Athens), Νικόλαος Κολιάκος(University General Hospital Attikon)
Cited by 21
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Infections Caused by<i>Scedosporium</i>spp
|Clinical Microbiology Reviews|2008|757
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
|Intensive Care Medicine|2012|449
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997–2002)
|Journal of Antimicrobial Chemotherapy|2006|194
European Surveillance of Antimicrobial Consumption (ESAC): Data Collection Performance and Methodological Approach
|British Journal of Clinical Pharmacology|2004|125